Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsdon Storey

Showing results (121-130 of 154) with videos related to

Pageof 16
Sort By:
ERJ Open Research|February 18, 2025
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudyStephanie A Ward, Robyn L Woods, Matthew T Naughton, et al.
Human Molecular Genetics|September 20, 2008
A duplication at chromosome 11q12.2-11q12.3 is associated with spinocerebellar ataxia type 20Melanie A Knight, Dena Hernandez, Scott J Diede, et al.
The Lancet. Healthy Longevity|February 16, 2026
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trialWalter P Abhayaratna, Christopher M Reid, Katherine L Webb, et al.
Molecular Psychiatry|January 28, 2021
Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trialMichael Berk, Bruno Agustini, Robyn L Woods, et al.
Aging Cell|May 27, 2021
Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older populationMoeen Riaz, Aamira Huq, Joanne Ryan, et al.
Respirology (Carlton, Vic.)|May 17, 2022
Sleep-disordered breathing was associated with lower health-related quality of life and cognitive function in a cross-sectional study of older adultsStephanie A Ward, Elsdon Storey, Danijela Gasevic, et al.
JAMA Psychiatry|June 4, 2020
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical TrialMichael Berk, Robyn L Woods, Mark R Nelson, et al.
Journal of General Internal Medicine|March 23, 2021
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older AdultsJessica E Lockery, Jonathan C Broder, Joanne Ryan, et al.
Contemporary Clinical Trials Communications|July 25, 2017
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD studyLiubov Robman, Robyn Guymer, Robyn Woods, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2023
Validation of newly derived polygenic risk scores for dementia in a prospective study of older individualsChenglong Yu, Joanne Ryan, Suzanne G Orchard, et al.
Pageof 16

Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
ERJ Open Research|February 18, 2025
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudyStephanie A Ward, Robyn L Woods, Matthew T Naughton, et al.
Human Molecular Genetics|September 20, 2008
A duplication at chromosome 11q12.2-11q12.3 is associated with spinocerebellar ataxia type 20Melanie A Knight, Dena Hernandez, Scott J Diede, et al.
The Lancet. Healthy Longevity|February 16, 2026
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trialWalter P Abhayaratna, Christopher M Reid, Katherine L Webb, et al.
Molecular Psychiatry|January 28, 2021
Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trialMichael Berk, Bruno Agustini, Robyn L Woods, et al.
Aging Cell|May 27, 2021
Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older populationMoeen Riaz, Aamira Huq, Joanne Ryan, et al.
Respirology (Carlton, Vic.)|May 17, 2022
Sleep-disordered breathing was associated with lower health-related quality of life and cognitive function in a cross-sectional study of older adultsStephanie A Ward, Elsdon Storey, Danijela Gasevic, et al.
JAMA Psychiatry|June 4, 2020
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical TrialMichael Berk, Robyn L Woods, Mark R Nelson, et al.
Journal of General Internal Medicine|March 23, 2021
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older AdultsJessica E Lockery, Jonathan C Broder, Joanne Ryan, et al.
Contemporary Clinical Trials Communications|July 25, 2017
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD studyLiubov Robman, Robyn Guymer, Robyn Woods, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2023
Validation of newly derived polygenic risk scores for dementia in a prospective study of older individualsChenglong Yu, Joanne Ryan, Suzanne G Orchard, et al.
Pageof 16